BioHealth News Archive
Novavax Announces Expanded Agreement with SK bioscience to Manufacture COVID-19 Vaccine Containing Omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes
GAITHERSBURG, Md., July 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, has…
Read More
Construction Continues at Progress Labs in Gaithersburg – The MoCo Show
Progress Labs at Progress Way in Gaithersburg, MD is a two-building approximately 495,000 SF development situated on 44 acres with I-270 visibility and access…
Read More
Maryland Inno – Maryland sees an increase in VC dollars in Q2 despite a national decline
Maryland bucked a national trend in venture capital funding in the second quarter of 2022, recording an increase in the number of companies able…
Read MoreMaryland Inno – Baltimore startup Delfi Diagnostics raises $225M with plans to change how lung cancer is diagnosed
Baltimore biotechnology startup Delfi Diagnostics has raised $225 million as it embarks on a 15,000-person trial for its early cancer detection technology. The oversubscribed…
Read More
BioFactura Announces Activation of a $15.9M Contract Option for its Smallpox Biodefense Therapeutic
The contract from BARDA will advance development of an antibody cocktail therapeutic for the treatment of smallpox. FREDERICK, MD. (PRWEB) JULY 15, 2022 BioFactura today…
Read MoreAltus Realty Acquires Pair of Rockville Office Buildings for $26M – Commercial Observer
Altus Realty has acquired Research Square, two office buildings comprising 90,000 square feet in Rockville, Md., for $25.5 million. Westat, an employee-owned research company…
Read More
Materic and LaunchPort Announce Partnership to Drive Advanced Materials Manufacturing for Medical Device Technology – The LaunchPort
July 18, 2022, Baltimore, MD – Materic, a custom manufacturer of advanced materials, and LaunchPort, LLC, a medical device venture center and GMP contract…
Read More
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors | Emergent BioSolutions Inc.
GAITHERSBURG, Md., July 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors appointed Sujata Dayal as…
Read More
D.C. region gets boost in CBRE’s new life sciences talent ranking – Washington Business Journal
A new CBRE report ranked the top 25 life sciences research talent clusters for the first quarter. {iframe}https://www.bizjournals.com/washington/news/2022/07/14/dc-area-life-sciences-research-talent-cbre-rank.html{/iframe}
Read More
Canon Medical Systems USA Inc. Announces Expansion of Distributorship with the Acquisition of NXC Imaging – Cardiac Vascular News
Tustin, California, July 11, 2022 (GLOBE NEWSWIRE) — Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation and a global…
Read More
NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers
First IND for NexImmune’s AIM nanoparticle platform in solid tumors IND clearance enables commencement of a clinical trial to evaluate NEXI-003, an autologous antigen-specific…
Read More
Novavax receives FDA authorization for its Covid vaccine – Washington Business Journal
The announcement comes days after the Biden administration reached a deal to buy 3.2 million doses. Image: Novavax has received emergency use authorization from…
Read More
FDA Grants Orphan Drug Designation (ODD) Status to Rockville’s NeoImmuneTech’s NT-I7 for the treatment of Glioblastoma Multiforme
· Glioblastoma multiforme is one of the most complex, deadly and treatment-resistant cancer with a 5-year survival rate of 6.8% and an average…
Read More
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
Jul 11, 2022 Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md., July…
Read More
MaxCyte Signs Strategic Platform License with LG Chem to Advance its Allogeneic CAR-T Programs
LG Chem to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of its T-cell therapy candidates for solid tumors GAITHERSBURG,…
Read More